Back
Intellia Therapeutics Vs. Ascendis Pharma AS Industry Stock Comparison
Sell
14
NTLA
Intellia Therapeutics
Last Price:
$9.50
Seasonality Move:
-6.53%
Sell
35
ASND
Ascendis Pharma AS
Last Price:
$128.13
Seasonality Move:
6.98%
Sell
14
Intellia Therapeutics (NTLA)
is a Sell
Is Intellia Therapeutics a Buy, Sell or Hold?
-
The current Intellia Therapeutics [NTLA] share price is $9.50. The Score for NTLA is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.
-
NTLA is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
35
Ascendis Pharma AS (ASND)
is a Sell
Is Ascendis Pharma AS a Buy, Sell or Hold?
-
The current Ascendis Pharma AS [ASND] share price is $128.13. The Score for ASND is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
-
ASND is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NTLA Stock Price Chart
What is Intellia Therapeutics's stock price today?
-
The Intellia Therapeutics share price today is $9.50Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NTLA is experiencing slight selling pressure.
ASND Stock Price Chart
What is Ascendis Pharma AS's stock price today?
-
The Ascendis Pharma AS share price today is $128.13Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ASND is experiencing selling pressure, which indicates risk of future bearish movement.
NTLA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.12 | Sell |
Relative Strength Index (14 RSI): | 27.37 | Sell |
Chaikin Money Flow: | -78316 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (10.51 - 13.09) | Sell |
Bollinger Bands (100): | (12.69 - 20.51) | Sell |
ASND Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.63 | Sell |
Relative Strength Index (14 RSI): | 41.37 | Sell |
Chaikin Money Flow: | -281370 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (132.04 - 139.32) | Sell |
Bollinger Bands (100): | (124.47 - 141.31) | Sell |
NTLA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 10.39 | Sell |
20-day SMA: | 11.39 | Sell |
50-day SMA: | 13.42 | Sell |
200-day SMA: | 20.23 | Sell |
8-day EMA: | 10.23 | Sell |
20-day EMA: | 11.34 | Sell |
50-day EMA: | 13.33 | Sell |
200-day EMA: | 19.74 | Sell |
ASND Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 132.64 | Sell |
20-day SMA: | 136.01 | Sell |
50-day SMA: | 132.35 | Sell |
200-day SMA: | 134.15 | Sell |
8-day EMA: | 132.62 | Sell |
20-day EMA: | 134.21 | Sell |
50-day EMA: | 133.61 | Sell |
200-day EMA: | 131.63 | Sell |
Intellia Therapeutics Earnings Growth & NTLA Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.11 per share, and an increase next year of $0.41 per share.
Ascendis Pharma AS Earnings Growth & ASND Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.51 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.31 per share, and an increase next year of $5.63 per share.
Intellia Therapeutics Technical Analysis
Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | Jan 13 | Jan 14 | Jan 15 | Jan 16 | Jan 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Jan | ||||||||||
03 | 06 | 07 | 08 | 10 | 13 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Ascendis Pharma AS Technical Analysis
Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | Jan 13 | Jan 14 | Jan 15 | Jan 16 | Jan 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Jan | ||||||||||
03 | 06 | 07 | 08 | 10 | 13 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |